Results 131 to 140 of about 439,784 (298)

Eugenol: An Insight Into the Anticancer Perspective and Pharmacological Aspects

Food Science &Nutrition, Volume 13, Issue 8, August 2025.
Eugenol (Eug), a volatile phenolic bioactive compound with formula of C10H12O2 have been reported with anticancer, antidiabetic, cardio‐ and pulmonary protective role. Moreover, it has the ability to improve gut health and prevent neurodegenerative disorders. According to WHO, the safe dose of Eug is 2.5 mg/kg for consumption.
Ahmad Mujtaba Noman, Muhammad Tauseef Sultan, Aimen Mazhar, Waqas Ahmad Khan, Muhammad Imran, Muzzamal Hussain, Ehab M. Mostafa, Ahmed H. El‐Ghorab, Mohammed M. Ghoneim, Samy Selim, Mohamed A. Abdelgawad, Entessar Al Jbawi, Suliman A. Alsagaby, Waleed Al Abdulmonem   +13 more
wiley   +1 more source

Allosteric modulation of beta1 integrin function induces lung repair in animal model of emphysema. [PDF]

, 2007
Emphysema is a progressive lung disease characterised by loss of lung parenchyma with associated functional changes including decreased tissue elastance. Here we report beta1 integrin is a novel target for tissue repair and regeneration in emphysema.
Chris J. Armit, David J. Harrison, Linda Wilson, Mark Marsden, Rehab J. Al-Jamal, Steven D. Shapiro, Susan McIntyre   +6 more
core   +1 more source

Evolving nutrition therapy in cystic fibrosis: Adapting to the CFTR modulator era

Nutrition in Clinical Practice, Volume 40, Issue 4, Page 816-828, August 2025.
Abstract Cystic fibrosis transmembrane regulator (CFTR)–directed therapies, such as modulators, have transformed the medical management of people with CF, resulting in better lung function, weight, and body mass index in recent years. With improved nutrition status in people on CFTR modulators, the emphasis on a high‐energy, high‐fat diet (the legacy ...
Kay Vavrina, Tara B. Griffin, Angel M. Jones, Terri Schindler, Trang N. Bui, Senthilkumar Sankararaman   +5 more
wiley   +1 more source

Prevalence of Pancreatic Steatosis and Its Associated Factors in Turkey: A Nation-Wide Multicenter Study

The Turkish Journal of Gastroenterology
Background/Aims: Pancreatic steatosis (PS) is a pathology associated with metabolic syndrome (MS), endocrin and exocrine disfunctions of the pancreas, and fatty liver. The data on the frequency of PS are very limited.
Orhan Sezgin, Serkan Yaraş, Mehmet Cindoruk, Elmas Kasap, Hakan Ünal, Aydın Şeref Köksal, Abdullah Emre Yıldırım, Burak Özşeker, Nevin Oruç , Müjde Soytürk, Sabite Kaçar, Muhsin Kaya , Kader Irak, Yasemin Gökden, Deniz Öğütmen Koç, Osman Özdoğan, Engin Altıntaş, Nergiz Ekmen, Murat Saruç, Şencan Acar, Mahmut Polat, Sezgin Barutçu, Göksel Bengi, Volkan Gökbulut , Nalan Gülşen Ünal , Dilek Oğuz   +25 more
doaj   +1 more source

Pancreatic elastases I and II in β-lactoglobulin hydrolysis: preliminary results [PDF]

, 1996
Christelle Desbois, Isabelle Le Huërou‐Luron, M. Gestin, V. Philouze-Romé, T. Lengagne, L. Roger, F. Mendy, Paul Guilloteau   +7 more
openalex   +1 more source

Cystic Fibrosis Year in Review 2024

Pediatric Pulmonology, Volume 60, Issue 8, August 2025.
ABSTRACT In 2024, important advances for people with cystic fibrosis (CF) were published. Important guidelines for newborn screening and care of infants diagnosed with CF transmembrane conductance regulator (CFTR)‐Related Metabolic Syndrome/Cystic Fibrosis Screen Positive Inconclusive Diagnosis (CRMS/CFSPID) were published alongside related key lessons
Adrienne P. Savant
wiley   +1 more source

Polymorphonuclear Pancreatic Elastase Measurement

Definitions, 2020

semanticscholar   +1 more source

Unravelling the heterogeneity of diabetes in chronic pancreatitis: Alpha and beta cell dysfunction and association with glycaemic control

Diabetic Medicine, Volume 42, Issue 8, August 2025.
Abstract Aims Diabetes in patients with chronic pancreatitis is a heterogeneous condition with some patients presenting with pre‐existing diabetes and others developing diabetes after pancreatitis onset. We aimed to characterise beta and alpha cell function in these patients and examine differences between those with and without pre‐existing diabetes ...
Line Davidsen, Simon Lebech Cichosz, Cecilie Siggaard Knoph, Isabelle Myriam Larsen, Peter Bisgaard Stæhr, Peter Vestergaard, Morten Hasselstrøm Jensen, Bolette Hartmann, Jens Juul Holst, Asbjørn Mohr Drewes, Caroline Trunk‐Black Juel, Filip Krag Knop, Søren Schou Olesen   +12 more
wiley   +1 more source

Current practice, challenges and future opportunities in the safety assessment of newly expressed proteins in genetically modified plants

EFSA Journal, Volume 23, Issue 8, August 2025.
Abstract Current risk assessment strategies for protein safety of newly expressed proteins (NEPs) in genetically modified (GM) plants are based on chemical risk assessment principles and Codex Alimentarius guidelines for biotech‐derived foods, initially published in 2003. These guidelines were designed for proteins with multiple testing options and for
EFSA Panel on Genetically Modified Organisms (GMO), Josep Casacuberta, Francisco Barro, Albert Braeuning, Ruud de Maagd, Michelle M. Epstein, Thomas Frenzel, Jean‐Luc Gallois, Frits Koning, Antoine Messéan, F. Javier Moreno, Fabien Nogué, Giovanni Savoini, Alan H. Schulman, Christoph Tebbe, Eve Veromann, Michele Ardizzone, Luca Belmonte, Martina Bonatti, Ian Dewhurst, Ivan Dimitrov, Arianna Ferrari, Tilemachos Goumperis, Kevin Hogeveen, Aleksandra Lewandowska, Robin Ornsrud, Nikoletta Papadopoulou, Konstantinos Paraskevopoulos, Tommaso Raffaello, Reinhilde Schoonjans, Elisabeth Waigmann, Elena Sánchez‐Brunete, Antonio Fernandez Dumont   +32 more
wiley   +1 more source

Functional and metabolic differences between elastase-generated fragments of human lipoprotein[a] and apolipoprotein[a]

Journal of Lipid Research, 1996
We have previously shown that a functional free apolipoprotein[a] (apo[a]) can be isolated from its parent lipoprotein[a] (Lp[a]) by a mild reductive procedure.
C Edelstein, J A Italia, O Klezovitch, A M Scanu   +3 more
doaj